We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.

Kanvas Biosciences, a Pangaea Ventures portfolio company, has published new research on its High-Phylogenetic-Resolution Spatial Mapping (HiPR-Map) Platform spectral imaging technology. This novel tool promises to transform how researchers visualize and analyze the complexities of the microbiome.

Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.

ESS Tech, Inc. announced that the company’s global fleet of LDES solutions has transacted nearly 2.5 GWh of transacted energy

The multi-party collaboration will enable embodied carbon reductions at NEOM's large scale construction projects.

Green hydrogen could deliver 10% of required emissions reductions needed to reach net-zero by 2050, particularly in hard-to-decarbonize sectors like heavy industry and long-haul transport.

Our decision to lead the Series C funding round for Green Theme Technologies' (GTT), a company making textile production more sustainable, underscores our commitment to breakthrough technologies that enable better, more sustainable outcomes for industry and the environment

Kanvas Biosciences, a full-stack spatial biology company, announced data from a clinical trial that produced results that de-risk the development of Kanvas Bio’s lead immuno-oncology drug.

Through its proprietary bioprinting technology, Aspect Biosystems creates functional human tissues with unprecedented precision and control. These 3D-printed tissues can restore a diseased state without the constraints of traditional organ transplantation.

Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, today announced that it has completed the acquisition of the Smart Packaging assets of TruTag Technologies.

CarbonCure Technologies has saved more than 500,000 metric tons of carbon dioxide (CO2) to date across 7.5 million truckloads of CarbonCure concrete. 

Agreement supports production scale-up to meet global demand for new crop solutions

Floré, a leader in gut health testing and customized probiotics, has launched its new line of probiotics specifically designed for neurodiversity. The new products, Pathways Support and Mood Support are formulated using extensive data from the company’s groundbreaking research study conducted in partnership with Arizona State University, which explored the positive impact of customized probiotic supplementation on individuals with autism spectrum disorder (ASD).

NewLeaf Symbiotics, the global leader in Pink Pigmented Facultative Methylotrophs (PPFMs), announces today the addition of Greg Thompson as an independent director to its Board.

Tidal Grow® AgriScience, a division of Tidal Vision Products Inc., has been awarded a Fertilizer Production Expansion Program (FPEP) grant by the USDA. This funding significantly increases production of the popular seafood hydrolysate liquid fertilizers Oceanic® and SeaPhos®.

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, today announced that it has received a $72.75 million investment from the Governments of Canada and British Columbia. 

Kanvas Biosciences, a full-stack spatial biology company, today announced it has raised $12.5 million in additional funding co-led by existing investors DCVC and Lions Capital LLC, and participation from FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures as well as existing investors.

ESS Tech, Inc. (ESS) (NYSE: GWH), a leading manufacturer of long-duration energy storage systems (LDES) for commercial and utility-scale applications, today announced that a financing package of $50 million was approved by the Export-Import Bank of the United States (EXIM) Board of Directors under the Make More in America Initiative.

Dr. Clauder’s has joined forces with protein pioneer Calysta to launch the world’s first dog treats made with FeedKind® Pet protein, a revolutionary new pet food ingredient.

Announced at the world’s leading pet trade fair, Interzoo, the groundbreaking air-dried treat presented by Dr. Clauder’s makes the most of Calysta’s nutritionally rich protein, which is produced by natural fermentation – making it a perfect non-GMO ingredient that meets market demands for nutritional quality, palatability, and health for pets.